BOX GER Week ended 24 Jul 2026

Weekly Investor Report

Becton, Dickinson and Company · Healthcare · Medical Instruments & Supplies

Latest close 137.1 EUR
2.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 3.0% above the Trend Line and sits at 50.8% of its 52-week range. The latest completed week returned 2.5%, after a 8.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal.

Setup score 43 out of 100
Latest Close 137.1 EUR 24 Jul 2026
1W Return 2.5% latest completed week
4W Return 8.9% short-term follow-through
12W Return 2.2% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 44.32% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 3.0% above the Trend Line and sits at 50.8% of its 52-week range. The latest completed week returned 2.5%, after a 8.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
16 Jan 23 Jan 30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.26

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 8.9% over four weeks, 2.2% over 12 weeks, and 21.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.5%
4W8.9%
12W2.2%
26W2.5%
52W21.3%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.16Latest activity-pressure read.
Pressure change81.7%Four-week change in activity pressure.
Leadership2.62Latest relative-leadership reading.
RS change183.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Sep 2025 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength65/100Blend of value, momentum, and quality. Underlying universe rank 36; rank 1 is best.
Value39/100Relative valuation strength. Underlying universe rank 62; rank 1 is best.
Quality74/100Profitability and accounting quality. Underlying universe rank 27; rank 1 is best.
Momentum69/100Medium-term price momentum. Underlying universe rank 32; rank 1 is best.
Growth69/100Revenue and earnings growth. Underlying universe rank 32; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework50/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.2x
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
11.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
46.8%
Gross profit retained from each unit of revenue.
Operating margin
14.5%
Operating profit retained from revenue.
Free-cash-flow margin
14.3%
Free cash flow generated from revenue.
Return on invested capital
5.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.2%
Latest one-year revenue growth.
EPS growth
-0.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-13.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.7%
Cash dividends relative to market value.
Buyback yield
6.6%
Net share repurchases relative to market value.
Shareholder yield
9.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 17 relevant articles.

2 positive · 14 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.4%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+9.6%Week of 13 Feb.
Worst week-6.0%Week of 23 Jan.
Latest week+2.5%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains12
Flat weeks0
Modest losses8
Sharp losses3
Recent vol3.4%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026137.1 EUR2.5%133.1 EUR147.9 EUR-0.162.6267Off
17 Jul 2026133.8 EUR0.5%132.9 EUR148.1 EUR-0.421.4550Off
10 Jul 2026133.1 EUR6.0%132.8 EUR148.3 EUR-0.610.2621Off
19 Jun 2026125.7 EUR-0.2%132.6 EUR148.6 EUR-0.86-4.83207Off
12 Jun 2026125.9 EUR-3.9%132.6 EUR148.8 EUR-0.89-3.151.3KOff
5 Jun 2026131.1 EUR3.8%132.6 EUR149.1 EUR-0.920.37580Off
29 May 2026126.3 EUR1.0%132.1 EUR149.4 EUR-0.82-4.43353Off
22 May 2026125.0 EUR2.4%131.9 EUR149.6 EUR-0.83-4.4935Off
15 May 2026122.1 EUR-5.5%131.8 EUR149.9 EUR-0.80-2.951.2KOff
8 May 2026129.2 EUR3.3%131.8 EUR150.2 EUR-0.791.151.4KOff
1 May 2026125.1 EUR-3.5%131.6 EUR150.4 EUR-0.91-1.74160Off
24 Apr 2026129.6 EUR-3.4%131.6 EUR150.7 EUR-0.772.67205On
17 Apr 2026134.2 EUR2.5%131.3 EUR150.9 EUR-0.603.57214On
10 Apr 2026131.0 EUR-2.6%130.8 EUR151.2 EUR-0.324.59268On
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.